Latest News in the pharma Industry

Top Stories

Teva Allowed to File NDA for Rhinitis Therapy

Teva Allowed to File NDA for Rhinitis Therapy

12 Aug 2011

The approval follows the results from two Phase III trials assessing the safety and efficacy of BDP Nasal HFA in the treatment of SAR and PAR.

Read more 
Russian Pharmaceutical Firms Collaborate for Innovative Treatments

Russian Pharmaceutical Firms Collaborate for Innovative Treatments

11 Aug 2011

The project will focus on developing treatments across three technological platforms.

Read more 
GNS Healthcare with BMS to Identify Biomarkers in Immuno-inflammation

GNS Healthcare with BMS to Identify Biomarkers in Immuno-inflammation

11 Aug 2011

GNS will use clinical and molecular information from a Bristol-Myers Squibb clinical trial to build computer models to identify key molecular mechanisms.

Read more 
Zydus & Zynesher Complete K-V Generics Acquisition for $60M

Zydus & Zynesher Complete K-V Generics Acquisition for $60M

10 Aug 2011

The acquisition covers K-V Pharma's certain packaging, manufacturing and laboratory facilities, as well as equipment specific to the generic business.

Read more 
India's CMO Ipca Acquires UK's Onyx Scientific

India's CMO Ipca Acquires UK's Onyx Scientific

10 Aug 2011

Ipca said its UK subsidiary has acquired Onyx Research Chemicals, the holding company of Onyx Scientific Ltd, a contract manufacturing organisation.

Read more 
Unigene & GSK Ink Pact for the Treatment of Osteoporosis in Postmenopausal Women

Unigene & GSK Ink Pact for the Treatment of Osteoporosis in Postmenopausal Women

9 Aug 2011

Unigene will receive up to approximately $2.2 million in milestone payments from GSK to undertake certain development and manufacturing activities.

Read more 
NICE Recommends against Novartis Multiple Sclerosis Drug for NHS Patients

NICE Recommends against Novartis Multiple Sclerosis Drug for NHS Patients

9 Aug 2011

The UK's healthcare regulators have recommended against the prescription of Novartis' multiple sclerosis drug Gilenya to NHS patients due to uncertainties over its clinical effectiveness.

Read more 
Researchers Work on Improving Influenza Vaccination for Broader Protection

Researchers Work on Improving Influenza Vaccination for Broader Protection

9 Aug 2011

From a public health perspective, an ideal influenza vaccine would protect against multiple strains of the virus, regardless of their hemagglutinin structure.

Read more 
Spaulding Clinical & Eurofins Optimed Announce Joint Partnership for Global Studies

Spaulding Clinical & Eurofins Optimed Announce Joint Partnership for Global Studies

9 Aug 2011

The partnership will leverage the strengths of both companies and facilitate collaboration on integrated clinical services to engage pharmaceutical clients who demand a global footprint.

Read more 
MolMed Signs with GSK for Gene Therapy Development

MolMed Signs with GSK for Gene Therapy Development

8 Aug 2011

Under the agreement, MolMed will develop a production process for an investigational gene therapy for ADA-SCID, a very rare disease that affects approximately 350 children worldwide.

Read more 
US Drug Approvals in 2011 Reach 2010 Total

US Drug Approvals in 2011 Reach 2010 Total

8 Aug 2011

The number of drug approvals is set to increase further, with more than a dozen drug candidates still scheduled for review before the end of the year.

Read more 
Pfizer Looks to Sell OTC Version of Lipitor

Pfizer Looks to Sell OTC Version of Lipitor

5 Aug 2011

Pfizer hopes to sell an over-the-counter version of its best-selling drug Lipitor when its generic forms are available in November.

Read more